skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Syphilis

(Last updated: May 7, 2013; last reviewed: May 7, 2013)

Syphilis

Member Financial Disclosure
Company Relationship
Bolan, Gail
Centers for Disease Control and Prevention None N/A
Ghanem, Khalil
Johns Hopkins University
Becton-Dickenson
Consultant, Honoraria
Hook, Edward W. 
University of Alabama at Birmingham
Becton-Dickenson
Honoraria, Research Support
Gen Probe
Research Support
GlaxoSmithKline
Research Support
Merck Honoraria
Siemens Research Support
Stoner, Brad
Washington University School of Medicine
None N/A
Wendel, George
University of Texas Southwestern
None N/A
Workowski, Kim*
Emory University
CDC Other
Gliead Consultant
Merck Consultant
Tibotec Research Support
Vertex Research Support
* Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top